Haematology and Haematotherapy
Lines of Research
01.Transplantation of hematopoietic precursors in adult and pediatric patients
02.CAR-T cell therapy (Chimeric Antigen Receptor-T): efficacy and quality of life studies
03.Study of rare diseases with a hematological basis: diagnosis and individualized treatment
04.Hemostasis and Thrombosis: Approach in the clinic and the laboratory of new therapies for patients with hemophilia. Digital tools for the management and analysis of information in hemophilia. Immune thrombocytopenia. Thrombophilia states of genetic and acquired origin. Thrombosis in Oncohematology
- Research projects
- Clinical studies
- Scientific Publications
- Technological Offers
- Industrial property records
No results
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
No results
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL study
Garcia-Sancho, AM; Bellei, M; Lopez-Parra, M; Gritti, G; Cortes, M; Novelli, S; Panizo, C; Petrucci, L; Gutierrez, A; Dlouhy, I; Bastos-Oreiro, M; Sancho, JM; Ramirez, MJ; Moraleda, JM; Carrillo, E; Jimenez-Ubieto, AI; Jarque, I; Orsucci, L; Garcia-Torres, E; Montalban, C; Dodero, A; Arranz, R; De las Heras, N; Pascual, MJ; Lopez-Jimenez, J; Spina, M; Re, A; De Villambrosia, SG; Bobillo, S; Federico, M; Caballero, D – 2022
Pharmacokinetic and clinical improvements after PK-guided switch from standard half-life to extended half-life factor VIII products
Megias-Vericat, JE; Boix, SB; Moreno, RB; Mingot-Castellano, ME; Lopez, MR; Hirnyk, MC; Arranz, JM; Villas, JMC; Guaita, SH; Meda, MM; Jaime, FL; Albo-Lopez, C; Palomero-Massanet, A; Seto, NV; Lecinena, IL; Haro, ARC; Andres, JLP – 2022
BOREAS: a global, phase III study of the MDM2 inhibitor navtemadlin (KRT-232) in relapsed/refractory myelofibrosis
Verstovsek, S; Al-Ali, HK; Mascarenhas, J; Perkins, A; Vannucchi, AM; Mohan, SR; Scott, BL; Woszczyk, D; Koschmieder, S; Garcia-Delgado, R; Laszlo, R; McGreivy, JS; Rothbaum, WP; Kiladjian, JJ – 2022
Procoagulant State of Sleep Apnea Depends on Systemic Inflammation and Endothelial Damage
Fernandez-Bello, I; Manzano, EM; Rio, FG; Sanz, RJ; Cubillos-Zapata, C; Casitas, R; Sanchez, B; Jaureguizar, A; Acuna, P; Alonso-Fernandez, A; Roman, MTA; Yuste, VJ; Butta, NV – 2022
Real-life analysis on safety and efficacy of asciminib for ponatinib pretreated patients with chronic myeloid leukemia
Luna, A; Perez-Lamas, L; Boque, C; Giraldo, P; Xicoy, B; Nuno, CR; Vega, MM; Alvarez-Larran, A; Salamanca, A; Garcia-Noblejas, A; Vall-Llovera, F; Villalon, L; De Las Heras, N; Ramila, E; Perez-Encinas, M; Cuevas, B; Perez-Lopez, R; Sanchez-Guijo, F; Jimenez-Velasco, A; Lakhwani, S; Casado, LF; Rosell, A; Escola, A; Fernandez, MJ; Garcia-Hernandez, C; Cervero, C; Mora, E; Sagues, M; Suarez-Varela, S; Velez, P; Mastell, PC; Bitaube, RF; Serrano, L; Cortes, M; Goni, JAV; Steegmann, JL; de Soria, VGG; Alonso-Dominguez, JM; Araujo, MC; Coll, AP; Hernandez-Boluda, JC; Garcia-Gutierrez, V – 2022
Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea
Alvarez-Larran, A; Garrote, M; Ferrer-Marin, F; Perez-Encinas, M; Mata-Vazquez, MI; Bellosillo, B; Arellano-Rodrigo, E; Gomez, M; Garcia, R; Garcia-Gutierrez, V; Gasior, M; Cuevas, B; Angona, A; Gomez-Casares, MT; Martinez, CM; Magro, E; Ayala, R; del Orbe-Barreto, R; Perez-Lopez, R; Fox, ML; Raya, JM; Guerrero, L; Garcia-Hernandez, C; Caballero, G; Murillo, I; Xicoy, B; Ramirez, MJ; Carreno-Tarragona, G; Hernandez-Boluda, JC; Pereira, A – 2022
Relationship between malnutrition and the presence of symptoms of anxiety and depression in hospitalized cancer patients.
Sanchez-Torralvo, FJ; Contreras-Bolivar, V; Ruiz-Vico, M; Abuin-Fernandez, J; Gonzalez-Almendros, I; Barrios, M; Olveira, G – 2022
Resistance to empirical beta-lactams recommended in febrile neutropenia guidelines in Gram-negative bacilli bloodstream infections in Spain: a multicentre study
Chumbita, M; Puerta-Alcalde, P; Yanez, L; Cuesta, MA; Chinea, A; Morales, IE; Abellan, PF; Gudiol, C; Guerreiro, M; Gonzalez-Sierra, P; Rojas, R; Pina, JMS; Vadillo, IS; Varela, R; Vazquez, L; Lopera, C; Monzo, P; Garcia-Vidal, C – 2022
SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disorders
Pinana, JL; Lopez-Corral, L; Martino, R; Vazquez, L; Perez, A; Martin-Martin, G; Gago, B; Sanz-Linares, G; Sanchez-Salinas, A; Villalon, L; Conesa-Garcia, V; Olave, MT; Corona, M; Marcos-Corrales, S; Tormo, M; Hernandez-Rivas, JA; Montoro, J; Rodriguez-Fernandez, A; Risco-Galvez, I; Rodriguez-Belenguer, P; Hernandez-Boluda, JC; Garcia-Cadenas, I; Ruiz-Garcia, M; Munoz-Bellido, JL; Solano, C; Cedillo, A; Sureda, A; Navarro, D – 2022
Clot Stiffness Measured By Seer Sonorheometry As a Marker Of Poor Prognosis In Hospitalized COVID-19 Patients.
Jose Lopez-Jaime, Francisco; Fernandez-Bello, Ihosvany; Martin-Tellez, Sandra; Doblas-Marquez, Alberto; Tesfay, Yohannes; Marquez-Gomez, Ignacio; Maria Reguera-Iglesias, Jose; Isidro Munoz-Perez, Manuel; Montano, Adrian – 2022
SARS-CoV-2-reactive antibody detection after SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group
Pinana, JL; Lopez-Corral, L; Martino, R; Montoro, J; Vazquez, L; Perez, A; Martin-Martin, G; Facal-Malvar, A; Ferrer, E; Pascual, MJ; Sanz-Linares, G; Gago, B; Sanchez-Salinas, A; Villalon, L; Conesa-Garcia, V; Olave, MT; Lopez-Jimenez, J; Marcos-Corrales, S; Garcia-Blazquez, M; Garcia-Gutierrez, V; Hernandez-Rivas, JA; Saus, A; Espigado, I; Alonso, C; Hernani, R; Solano, C; Ferrer-Lores, B; Guerreiro, M; Ruiz-Garcia, M; Munoz-Bellido, JL; Navarro, D; Cedillo, A; Sureda, A – 2022
Experience of the Spanish Group for Hematopoietic Transplantation (GETMON-GETH) in allogenic hematopoietic stem cell transplantation in Philadelphia acute lymphoblastic leukemia
Gomez, VG; Regano, LD; Villa, AR; Rubio, CD; Vicent, MG; Serra, IB; Fernandez, JM; Martinez, AIP; Hurtado, JMP; Duarte, ML; Regalado, MSM; Perez-Martinez, A – 2022
Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study
White, HE; Salmon, M; Albano, F; Andersen, CSA; Balabanov, S; Balatzenko, G; Barbany, G; Cayuela, JM; Cerveira, N; Cochaux, P; Colomer, D; Coriu, D; Diamond, J; Dietz, C; Dulucq, S; Engvall, M; Franke, GN; Gineikiene-Valentine, E; Gniot, M; Gomez-Casares, MT; Gottardi, E; Hayden, C; Hayette, S; Hedblom, A; Ilea, A; Izzo, B; Jimenez-Velasco, A; Jurcek, T; Kairisto, V; Langabeer, SE; Lion, T; Meggyesi, N; Mesanovic, S; Mihok, L; Mitterbauer-Hohendanner, G; Moeckel, S; Naumann, N; Nibourel, O; Leibundgut, EO; Panayiotidis, P; Podgornik, H; Pott, C; Rapado, I; Rose, SJ; Schafer, V; Touloumenidou, T; Veigaard, C; Venniker-Punt, B; Venturi, C; Vigneri, P; Vorkinn, I; Wilkinson, E; Zadro, R; Zawada, M; Zizkova, H; Muller, MC; Saussele, S; Ernst, T; Polakova, KM; Hochhaus, A; Cross, NCP – 2022
Ability of final PET/CT to predict response to first-line treatment in real patients with classical Hodgkin lymphoma.
Galvez-Carvajal, L; Quero, C; Casanova, M; Diaz, C; Chicharo, JR; Espeso, M; Medina, A; Ramos, I; Alba, E; Rueda, A – 2022
Haploidentical hematopoietic stem cell transplantation in pediatric and adolescent patients: A study of the Spanish hematopoietic stem cell transplantation group (GETH)
Ochoa-Fernandez, B; Galan-Gomez, V; Mestre, C; Gonzalez-Vicent, M; Pascual, A; Alonso, L; Regueiro, A; Plaza, M; Hurtado, JMP; Benito, A; Fuster, JL; Bueno, D; Mozo, Y; Vicario, JL; Balas, A; Sisinni, L; de Heredia, CD; Perez-Martinez, A – 2022
The economic cost of not coding disease-related malnutrition: A study in cancer inpatients,
Ruiz-Garcia, I; Contreras-Bolivar, V; Sanchez-Torralvo, FJ; Ulloa-Diaz, O; Ruiz-Vico, M; Abuin-Fernandez, J; Barrios-Garcia, M; Alba-Conejo, E; Olveira, G – 2022
Activated prothrombin complex concentrate to treat bleeding events in acquired hemophilia A: BAHAS study
Mingot-Castellano, ME; Garcia-Candel, F; Benitez-Hidalgo, O; Marco, A; Navarro, GAM; Perez-Montes, R; Donas, GG; Canaro, M; Paloma, MJ; Asenjo, B; Calle-Gordo, VM; Gonzalez, NP; Gonzalez, RR; Caparron-Miranda, IS; Paris, LQ; Herrero, S; Nunez, R – 2022
Impact of in vivo T-cell depletion in patients with myelodysplastic syndromes undergoing allogeneic hematopoietic stem cell transplant: a registry study from the Chronic Malignancies Working Party of the EBMT
Forcade, E; Chevret, S; Finke, J; Ehninger, G; Ayuk, F; Beelen, D; Koster, L; Ganser, A; Volin, L; Sengeloev, H; Michallet, M; Tischer, J; Jindra, P; Cascon, MJP; Koc, Y; Arat, M; Tomaszewska, A; Hayden, P; de Witte, T; Yakoub-Agha, I; Kroger, N; Robin, M – 2022
Treatment of COVID-19 with convalescent plasma in patients with humoral immunodeficiency – Three consecutive cases and review of the literature;
Delgado-Fernandez, M; Garcia-Gemar, GM; Fuentes-Lopez, A; Munoz-Perez, MI; Oyonarte-Gomez, S; Ruiz-Garcia, I; Martin-Carmona, J; Sanz-Canovas, J; Castano-Carracedo, MA; Reguera-Iglesias, JM; Ruiz-Mesa, JD – 2022
Impact of Individual Comorbidities on Survival of Patients with Myelofibrosis
Garcia-Fortes, M; Hernandez-Boluda, JC; Alvarez-Larran, A; Raya, JM; Angona, A; Estrada, N; Fox, L; Cuevas, B; Garcia-Hernandez, MC; Gomez-Casares, MT; Ferrer-Marin, F; Saavedra, S; Cervantes, F; Garcia-Delgado, R – 2022
No results
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Members
-
Researcher in ChargeSerá Investigador de este nivel los Investigadores Responsable que lideren un grupo de investigación del Instituto y sus Co-IR. Esta categoría puede incluir investigadores muy excepcionales en su disciplina.

Francisco José López Jaime
-
Investigador/a SéniorSerán aquellos que tengan una actividad investigadora de al menos 5 años en la etapa posdoctoral. Estos investigadores estarán adscritos a un Grupo de Investigación liderado por un Investigador Responsable. Las funciones serán las que le tenga asignadas su IR.
Pueden liderar una línea de investigación de alguno de los grupos de investigación del Instituto, con financiación competitiva propia, y con potencial para llegar a convertirse responsable de un grupo de investigación.
No results
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
-
Investigador/a Asistencial Colaborador/aSerá Investigador Asistencial Colaborador el Investigador que no reúne la consideración de Investigador Posdoctoral. Estarán adscritos a un Grupo de Investigación liderado por un IR. Las funciones serán las que le tenga asignada su IR.
No results
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
-
Investigadores/as posdoctorales y/o juniorEsta etapa posdoctoral estará restringida a Investigadores del Instituto que tengan el título doctor y no contemplados en los perfiles posteriores. Durante su etapa posdoctoral pueden llegar a liderar proyectos de I+D+i como Investigadores Principales, aunque aún no hayan establecido un nivel significativo de independencia. Además, pueden tener actividades de docencia y/o asistencial más allá de su trabajo de investigación.
No results
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
-
Technical staff
Los investigadores predoctorales y/o en formación serán aquellos investigadores que realizan investigaciones bajo supervisión en una línea de investigación orientada a la resolución de problemas de salud. Incluye aquellos investigadores que están cursando un doctorado (incluyendo a los contratados Río Hortega)
No results
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.